Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The Microbiome

Jose U. Scher, MD, Steven B. Abramson, MD  |  Issue: November 2011  |  November 1, 2011

Among environmental risk factors studied in relationship with RA development, the most notable examples include hormones, smoking, alcohol, and infection. Multiple viruses and bacteria have been associated with disease incidence but, to date, causation could not be established. Given the central role of host–microbe interactions, massively parallel DNA-sequence analyses of human microbiomes now offer the potential for important new insights relevant to autoimmune processes. One of the more intriguing environmental covariates modulating autoimmunity involves bidirectional crosstalk between the host and the oral and intestinal microbiomes (see Figure 1).

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Figure 1

Figure 1
click for large version

Host–microbiota interactions in health and inflammatory arthritis. A: In healthy individuals, a well balanced host–microbial cross-talk is essential for the maintenance of homeostasis. A thick mucus layer and epithelial cells prevent direct contact with the gut-associated immune cells, which constantly survey the contents of the intestinal lumen and eliminate undesired antigens. Commensal bacteria, such as Bacteroides fragilis, can activate pro tolerogenic machinery. A specific cell wall component, PSA, is sufficient to induce TREG-cell activation, IL-10 production, and TH17-cell repression to avoid uncontrolled inflammation. B: When either genetic or environmental factors alter the balance in the microbiota composition, dysbiosis ensues. Potentially harmful micro-organisms (such as SFB or Lactobacillus) predominate and local expansion of proinflammatory cells (TH17 cells, TH1 cells and others) occurs via different molecules (such as ATP, SAA, or CCL5 signaling). These autoreactive T cells migrate to peripheral immune compartments and activate B cells to differentiate into autoantibody-producing plasma cells. These cells and antibodies then migrate to synovial tissue where the inflammatory cascade is amplified through the activation of effector components, including macrophages, fibroblasts, osteoclasts, cytokines, and proteinases. If self-perpetuating, this process can lead to arthritis and pannus formation.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Abbreviations: ATP, adenosine-5′-triphosphate; CCL5, CC-chemokine ligand 5; IFNγ, interferon γ; IL-17, interleukin-17; PSA, polysaccharide A; SAA, serum amyloid A; SFB, segmented filamentous bacteria; TH1, type 1 T helper cell; TH17, type 17 T helper cell; TREG, regulatory T cell.

Source: Nat Rev Rheumatol. 2011;7:569-578. Reproduced with permission of Nature Pub. Group.

The roots for this appealing notion can be traced many centuries back. In the 1600s, and in the midst of the Great Plague, a devoted and simple Dutch tradesman named Antony van Leeuwenhoek managed to see beyond the tangible. His innovation was a combination of magnifying lenses and metallic skeletons which gave birth to a peculiar creature that would modify science forever: the microscope. With this instrument, van Leeuwenhoek made his most fascinating discovery. Diminutive forms of life, invisible to the bare eye, populated our body cavities and most surfaces on earth.

Page: 1 2 3 4 5 6 7 8 | Single Page
Share: 

Filed under:ConditionsResearch RheumRheumatoid Arthritis Tagged with:bacteriaMicrobiomePathogenesisRAResearchRheumatoid arthritis

Related Articles
    The Microbiome in Pediatric Rheumatic Diseases

    The Microbiome in Pediatric Rheumatic Diseases

    April 15, 2016

    The human intestinal microbiota is home to more than 1,000 bacterial species, containing approximately 3 million genes, many of which code for functions that have the potential to affect human physiology.1 Smaller numbers of organisms are also present in the skin, upper gastrointestinal tract, female reproductive tract and the oro- and nasopharynx. As tools have…

    Research Provides Insight into Impact of Microbiome on Health, Rheumatic Disease

    April 15, 2016

    The microbiome comprises diverse microbial flora, including bacteria, viruses and fungi, that live on mucosal surfaces, predominantly the skin and digestive tract. Microbes evolved billions of years prior to the development of modern Homo sapiens 200,000 years ago; we have always existed with their ubiquitous presence. Despite this, the first microbe was not visualized until…

    Research Suggests Th17 Cells Have Microbiota-Dependent Role in RA

    March 18, 2019

    A growing body of research is elucidating the role of intestinal microbiota in several auto­immune diseases, including rheumatoid arthritis (RA). Research published in December 2018 Arthritis & Rheumatology increases our understanding of the “extent and nature of mucosal immune activation during preclinical arthritis.”1 The research objective, according to the report, was to “dissect intestinal mucosal immune…

    Anatomy Insider / shutterstock.com

    Gut Instinct: Ankylosing Spondylitis & the Microbiome

    October 3, 2019

    CHICAGO—At the 2019 ACR State-of-the-Art Clinical Symposium, an annual gathering featuring talks by key opinion leaders on the most salient topics for practicing rheumatologists and healthcare providers, Jose U. Scher, MD, director of the Microbiome Center for Rheumatology and Autoimmunity at NYU Langone Medical Center, New York City, was the featured speaker. In his remarks,…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences